United States Patient Temperature Management - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026 - 2031)

According to Mordor Intelligence, the united states patient temperature management market size was valued at USD 1.28 billion in 2025 and is estimated to grow from USD 1.38 billion in 2026 to reach USD 1.98 billion by 2031, at a CAGR of 7.51% during the forecast period (2026-2031).

This report is Segmented by Product Type (Patient Warming Systems, Patient Cooling Systems, Accessories & Disposables), Application (Perioperative Care, Cardiac Arrest and Critical Care, Neurology and Neurocritical Care, and More), and End User (Hospitals, Ambulatory Surgical Centers, and More). The Market Forecasts are Provided in Terms of Value (USD).

United States Patient Temperature Management Market Trends and Insights

Rising Surgical Volumes And Perioperative Normothermia Protocols

The US patient temperature management market is seeing broad support from rising surgical activity in outpatient settings, where portable and rapid-cycle warming systems are easier to deploy than fixed hospital-style equipment. Outpatient facilities now handle more than 80% of surgical procedures in the United States, which has shifted a larger share of device demand toward smaller footprints and faster room turnover. MedPAC reported that ASC procedure volume per Medicare beneficiary grew 3.4% in 2024, which was well above the 2019-2023 average annual rate of 1.0%. That migration is changing procurement behavior because many ASC locations now weigh per-case cost and operational simplicity more heavily than feature density. AORN reported in 2025 that 90.35% of outpatient facility respondents used forced-air warming systems, which shows how deeply warming devices are embedded in perioperative workflows even amid litigation noise. The US patient temperature management market is also gaining from stronger compliance pressure around perioperative temperature control, which supports recurring disposable demand as much as capital equipment placement.

Higher Cardiac-Arrest And Neurocritical-Care Temperature-Control Use

The US patient temperature management market is also being lifted by updated post-resuscitation guidance that requires active fever prevention after cardiac arrest rather than simple observation. The 2025 American Heart Association guidance recommends preventing fever at or below 37.5°C for at least 72 hours in adults who remain comatose after return of spontaneous circulation. European guidance published in Intensive Care Medicine in 2025 aligns with that approach, which keeps device demand intact even as the clinical focus shifts away from routine deep hypothermia. In neurocritical care, updated consensus recommendations continue to favor automated feedback-controlled temperature management for intracerebral hemorrhage, subarachnoid hemorrhage, and acute ischemic stroke patients who require ICU admission. Severe traumatic brain injury care is following the same pattern, with controlled normothermia recognized as a therapeutic option in advanced ICU protocols. This widens the addressable pool for the US patient temperature management market beyond surgical warming and ties growth more closely to critical care pathways.

High Capital And Disposable Costs

Capital intensity remains a real brake on the US patient temperature management market, especially for dual-mode and closed-loop platforms that require a larger up-front commitment. Smaller hospitals and independent ASCs have to balance those capital costs against narrower budgets and lower qualifying case volumes. The burden does not stop at the controller because intravascular catheters, gel pads, warming blankets, and fluid-warming sets create recurring spend with every case. That pressure is harder to absorb when facilities are paid through bundled outpatient structures instead of separate reimbursement for temperature-control products. Independent ASC operators are especially price sensitive, which often pushes them toward single-vendor disposable contracts and slows adoption of newer systems from smaller suppliers. Leasing and subscription models help in some cases, but uptake has been uneven, so cost remains a clear restraint on the US patient temperature management market.

Other drivers and restraints analyzed in the detailed report include:

1. Closed-Loop And Dual-Mode Platform Upgrades
2. NICU Thermoregulation Monitoring Upgrades
3. Recalls And Fluid-Warmer Safety Risks

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Patient Warming Systems held 62.31% of the US patient temperature management market share in 2025, and the segment is also projected to grow at an 8.38% CAGR through 2031. That combination shows that warming remains the operational backbone of the US patient temperature management market across perioperative care, critical care, and neonatal use. The installed base is expanding in 2 ways at the same time, with higher disposable pull-through at existing accounts and new placements in ASCs and specialty clinics. Forced-air warming remains the most common modality by installed base, supported by the 2025 AORN survey showing use in 90.35% of outpatient facilities. Conductive and resistive warming systems are also gaining traction where infection-control concerns are changing preference in orthopedic operating rooms, and a 2026 study in Scientific Reports found conductive warming could achieve outcomes comparable to forced-air warming when pre-warming was used.

Blood and IV-fluid warmers continue to serve a separate but important role in delivering normothermic fluids to hemorrhage and hypothermia-risk patients. That niche is supported by military trauma guidance that specifies warmed blood products at 38-42°C in battlefield and prehospital resuscitation scenarios. Neonatal warmers and hybrid incubator-warmer platforms are also benefiting from the broader NICU quality push, which is expanding the US patient temperature management industry into more integrated thermoregulation workflows. On the cooling side, patient cooling systems remain smaller by revenue, but they are gaining value in cardiac arrest and neurocritical care because precision servo-control and multimodality treatment are becoming more important in ICU practice.

List of Companies Covered in this Report:

1. Augustine Surgical
2. AVAcore Technologies, Inc.
3. Barkey
4. Beckton Dickinson
5. Belmont Medical Technologies
6. Cincinnati Sub-Zero Products (Gentherm legacy brand)
7. Dragerwerk
8. Enthermics Medical Systems
9. Gentherm
10. Inspiration Healthcare Group plc
11. Medline Industries
12. Medtronic
13. QinFlow, Inc.
14. Smiths Group
15. Solventum Corporation
16. Stryker
17. TSC Life
18. ZOLL Medical Corporation (Asahi Kasei Corporation)

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support